Arturo Morales is Vice President of Data and Technology Solutions for WCG Analgesic Solutions. Dr. Morales has 20 years of experience working in the biotech/pharma industry in all aspects of data science and biology spanning the entire R&D spectrum.   Prior to the WCG acquisition, he oversaw all technical and data science operations at Analgesic Solutions including the development and commercialization of the Company’s proprietary Quantitative Data Surveillance System (QDSS) and Learning management system (aLearn).

Art started his industry career with Genome Therapeutics as a Senior Computational Biologist. He subsequently led a variety of teams at various companies including the Novartis Institutes for Biomedical Research, where he was Global lead for Biology Platform Informatics and responsible for the integration of all research data into a new data warehouse and the development of new data management and dashboard applications. Prior to Novartis, he was head of Biology and Informatics at Concert Pharmaceuticals, where he led all data and in vivo/in vitro biology studies that were pivotal in raising 2 rounds of VC funding and out-licensing of multiple drugs currently under development with various partner companies.   He was also the founder of a digital health company that integrated traditional health metrics with a variety of data feeds in order to better identify trends and improve health outcomes.

Art holds a B.Sc. in biochemistry/biophysics from Rensselaer Polytechnic Institute (RPI).  He completed his PhD. in Biology with an emphasis in bioinformatics and structural biology/biophysics with Dr. Paul Schimmel at the Massachusetts Institute of Technology (MIT).  Art is fluent in English and Spanish and holds black belts in Brazilian JiuJitsu and Karate.

Speaker has no relevant relationships with financial interests to disclose.